menu search

PFE / Seeking High Dividends? 3 Fairly Valued/Undervalued High Dividend Yield Stocks For Your Portfolio

Seeking High Dividends? 3 Fairly Valued/Undervalued High Dividend Yield Stocks For Your Portfolio
High dividend yield companies are valuable assets for your portfolio, since they are a great way to generate added income, which you can reinvest or use it to pay your bills. In today's article, I will present you with three companies that pay an attractive Dividend Yield, have a relatively low Valuation, and a 24M Beta Factor below 1. Being available for an attractive Valuation and having a Beta Factor below 1, these high dividend yield companies can help reduce your investment portfolio's volatility and risk level. Read More
Posted: Nov 4 2023, 15:00
Author Name: Seeking Alpha
Views: 022643

PFE News  

Seeking High Dividends? 3 Fairly Valued/Undervalued High Dividend Yield Stocks For Your Portfolio

By Seeking Alpha
November 4, 2023

Seeking High Dividends? 3 Fairly Valued/Undervalued High Dividend Yield Stocks For Your Portfolio

High dividend yield companies are valuable assets for your portfolio, since they are a great way to generate added income, which you can reinvest or u more_horizontal

Should You Pick Pfizer Stock At $30?

By Forbes
November 3, 2023

Should You Pick Pfizer Stock At $30?

Pfizer (NYSE: PFE) reported its Q3 results earlier this week, with revenues missing but earnings beating the street estimates, and we believe that PFE more_horizontal

There's a Silver Lining in Pfizer's Dark Cloud. Should You Buy the Stock?

By The Motley Fool
November 3, 2023

There's a Silver Lining in Pfizer's Dark Cloud. Should You Buy the Stock?

Pfizer reported an adjusted loss of nearly $1 billion in the third quarter, and recently lowered its forecasts for coronavirus product sales. The comp more_horizontal

This High-Yield Dividend Stock Is a Proven Wealth Creator

By The Motley Fool
November 2, 2023

This High-Yield Dividend Stock Is a Proven Wealth Creator

In 2023, the broader market has ignored the deep value proposition of most large-cap pharmaceutical stocks. Pfizer, a stalwart of the industry, has be more_horizontal

UK regulator approves Pfizer's hair loss drug

By Reuters
November 1, 2023

UK regulator approves Pfizer's hair loss drug

Britain's medicines regulator on Wednesday approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease. more_horizontal

Pfizer Posted a Steep Loss. Is It Time to Sell?

By The Motley Fool
November 1, 2023

Pfizer Posted a Steep Loss. Is It Time to Sell?

Pfizer reported third-quarter results on Tuesday, Oct. 31. The company told investors it had to write down $5.6 billion worth of unused inventory in t more_horizontal

Pfizer quarterly results hit by soft demand for COVID-19 products

By Fox Business
October 31, 2023

Pfizer quarterly results hit by soft demand for COVID-19 products

Sales of the company's coronavirus vaccine Comirnaty dropped 70% during the third quarter compared with the same period a year earlier, Pfizer reporte more_horizontal

We are keen to join forces with Seagan, says Pfizer CEO Albert Bourla

By CNBC Television
October 31, 2023

We are keen to join forces with Seagan, says Pfizer CEO Albert Bourla

Pfizer Chairman and CEO Albert Bourla joins 'Mad Money' host Jim Cramer to talk Q3 earnings results, partnering with Kansas City Chiefs Tight End Trav more_horizontal


Search within

Pages Search Results: